Xortx Therapeutics Inc Share Price

NASDAQ: XRTX

Small Cap

$0.85

(+0.47%)

as on September 17, 2025 at 1:29 am IST

$₹

Xortx Therapeutics Inc Stock Performance

as on September 17, 2025 at 1:29 am IST

Day's Low
Day's High
$0.83
Day's Price Range
$0.87
$0.85
2.35%
Downside
2.35%
Upside
52 Week's Low
52 Week's High
$0.66
52-Week Price Range
$2.51
$0.85
22.26%
Downside
195.29%
Upside

Xortx Therapeutics Inc share price movements today

Previous Close: $0.85
Open: $0.85
Volume: 276.1K
Day's Low - High: $0.83 - $0.87
52 Week Low - High: $0.66 - $2.51

Xortx Therapeutics Inc Historical Returns

1 Month Return: + 0.52 %
3 Month Return: -5.12 %
1 Year Return: -55.58 %
3 Year Return: -35.45 %
5 Year Return: 0 %

Xortx Therapeutics Inc Stock Fundamentals & Key Indicators

Check Xortx Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.3M

EPS (TTM)

-1.574

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.97%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-2.6M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Xortx Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Xortx Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Xortx Therapeutics Inc	BUY	$4.3M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Stock Returns calculator for Xortx Therapeutics Inc Stock including INR - Dollar returns

The Xortx Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Xortx Therapeutics Inc investment value today

Current value as on today

₹50,566

Returns

₹49,434

(-49.43%)

Returns from Xortx Therapeutics Inc Stock

₹54,301 (-54.3%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Xortx Therapeutics Inc Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for Xortx Therapeutics Inc. Average target price of $14.53

Xortx Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Xortx Therapeutics Inc.

What analysts predicted

94.15%UPSIDE

Target Price

$14.53

Current Price

$0.85

Analyzed by

5 Analysts

Target

$14.53

Xortx Therapeutics Inc target price $14.53, a slight upside of 94.15% compared to current price of $0.85. According to 5 analysts rating.

Xortx Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Xortx Therapeutics Inc Stock has decreased by -14% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:-14% versus previous 30 day period

Xortx Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	-	0	0	0
Operating Income	-1	-1	-1	-4	0	-3	-1	0	0	0
EBITDA	-1	-1	-1	0	0	-1	0	0	0	0
Interest Expense	-	-	-	-	0	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-1	-1	-1	2	-3	0	0	0	0	0
Income Tax Expense	0	0	0	-3	1	0	-	-	-	-
Net Income	-1	-1	-1	2	-3	0	0	0	0	0
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Xortx Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-	-
Gross Profit	-	0	0	0	0	0	0	-
Operating Income	0	-1	0	-1	-4	-10	-4	-3
EBITDA	0	-1	0	-1	-1	-9	-4	-3
Interest Expense	0	0	0	0	0	-	-	-
Depreciation	0	0	0	0	0	0	0	0
Income Before Tax	0	-3	0	-1	-1	-6	-2	-4
Income Tax Expense	0	0	0	0	0	-	-	-
Net Income	0	-2	0	-1	-1	-5	-2	-4
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Xortx Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Dec 2024
Net Income	-1	-1	2	-3	0
Operating Cash Flow	-1	-1	-1	-1	0
Investing Cash Flow	0	0	0	0	-
Financing Cash Flow	0	0	0	1	1
Change in Cash	-1	-1	-1	0	0

Xortx Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-3	-1	-1	-6	-2	-3
Operating Cash Flow	-1	0	-4	-8	-6	-3
Investing Cash Flow	0	0	0	0	0	0
Financing Cash Flow	1	0	19	4	0	2
Change in Cash	0	0	14	-3	-6	0

Global Institutional Holdings in Xortx Therapeutics Inc

Funds	Holdings
Hartland & Co	0.01%
UBS Group AG	0%
Royal Bank of Canada	0%
Armistice Capital, LLC	0%
Advisor Group Holdings, Inc.	0%

Insights on Xortx Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 150.1%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 124.9%
NEGATIVE IMPACT
Price Dip
In the last 6 months, XRTX stock has moved down by -15.8%

About Xortx Therapeutics Inc

xortx therapeutics inc., a bio-pharmaceutical company, focuses on the development and commercialization of therapies to treat progressive kidney diseases worldwide. it has two lead programs, including treatments for progressive kidney disease due to diabetes, diabetic nephropathy and polycystic kidney disease. the company focuses on developing therapies for health consequences that includes pre-diabetes, diabetes, and cardiovascular disease. in addition, it develops uric acid lowering agents to treat diabetic nephropathy, hypertension, insulin resistance, metabolic syndrome, and diabetes; and xanthine oxidase inhibitors. the company has a strategic alliance with teijin pharma limited to develop tmx-049, a xanthine oxidoreductase; and a partnership with the icahn school of medicine to study the incidence of acute kidney injury and hyperuricemia in patients hospitalized with covid-19. xortx therapeutics inc. is headquartered in calgary, canada.

Organisation	Xortx Therapeutics Inc
Headquarters	3710 ? 33rd Street NW, Calgary, AB, Canada, T2L 2M1
CEO	Dr. Allen Warren Davidoff Ph.D.
E-voting on shares	Click here to vote

Key Management of Xortx Therapeutics Inc

Name	Title
Dr. David MacDonald Ph.D.	Consultant of Clinical Operations
Ms. Charlotte May	Corporate Secretary
Dr. Allen Warren Davidoff Ph.D.	Founder, CEO, President & Director
Dr. Michael Scott Bumby D.V.M., M.B.A.	Chief Financial Officer
Dr. Stephen Haworth M.D., MRCP	Chief Medical Officer
Dr. Stacy Evans M.B.A., M.D.	Chief Business Officer
Nick Rigopoulos	Director of Communications
Dr. David Sans M.B.A., Ph.D.	Director of Corporate Development

FAQs

What is Xortx Therapeutics Inc share price today?

Xortx Therapeutics Inc share price today is $0.85 as on September 17, 2025 at 1:29 am IST at the close of the market. Xortx Therapeutics Inc share today touched a day high of $0.87 and a low of $0.83.

What is the 52 week high and 52 week low for Xortx Therapeutics Inc share?

Xortx Therapeutics Inc share touched a 52 week high of $2.51 on October 15, 2024 and a 52 week low of $0.66 on August 1, 2025. Xortx Therapeutics Inc stock price today i.e. September 17, 2025 at 1:29 am IST is closed at $0.85,which is 66.14% down from its 52 week high and 28.63% up from its 52 week low.

What is Xortx Therapeutics Inc's market capitalisation today?

Xortx Therapeutics Inc market capitalisation is $0.00T as on September 17, 2025 at 1:29 am IST.

How to invest in Xortx Therapeutics Inc Stock (XRTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Xortx Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Xortx Therapeutics Inc Shares that will get you 1.7647 shares as per Xortx Therapeutics Inc share price of $0.85 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Xortx Therapeutics Inc Stock (XRTX) from India?

Indian investors can start investing in Xortx Therapeutics Inc (XRTX) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 3:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Xortx Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 3:39 am IST). Based on Xortx Therapeutics Inc share’s latest price of $0.85 as on September 17, 2025 at 1:29 am IST, you will get 11.7647 shares of Xortx Therapeutics Inc. Learn more about fractional shares .